Christiane Pott

12PUBLICATIONS
98CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 14, 2026
Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial.

|Nov 03, 2025
Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trial.

Mouhamad Khouja, Elisa Genuardi, Simone Ferrero

|Oct 28, 2025
ctDNA dynamics demonstrates rapid treatment response to tafasitamab + R-CHOP +/- lenalidomide and predicts outcome in diffuse large B-cell lymphoma: results from the phase 1b First-MIND study.

Mouhamad Khouja, Britta Kehden, Derek Blair

|Apr 24, 2025
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study.

Clémentine Sarkozy, Loïc Chartier, Vincent Ribrag

|Sep 16, 2024
Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trials.

Mouhamad Khouja, Linmiao Jiang, Karol Pal

|May 14, 2024
Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines.

Vincent H J van der Velden, Isabel Dombrink, Julia Alten

Pageof 2

Frequent Collaborators

7 joint publications

Eva Hoster

5 joint publications

Linmiao Jiang

3 joint publications

Mouhamad Khouja

3 joint publications

Martin Dreyling